Healio
SearchLoading
Healio
SearchLoading
More about

Chronic Glycemic Control

News
November 20, 2024
2 min read
Save

GLP-1RAs confer ‘metabolic benefit,’ lower odds for MASLD after liver transplantation

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated steatotic liver disease after liver transplantation, noted a presenter at The Liver Meeting.

CME
Video

DIABESITY DIALOGUES | Patient Perspectives for PCPs: Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders

1.00 AAPA
1.00 NCPD
60 MINS
$0 FEE
CME
Video

Harnessing the Power of the Community to Battle Obesity

2.00 AAPA
2.00 CME
120 MINS
$0 FEE
CME
Video

Build Your Own Case Study | Obesity: Treating the Whole Patient

1.00 CME
1.00 NCPD
60 MINS
$0 FEE
News
January 25, 2022
1 min read
Save

KDIGO bases new tools on 2020 clinical practice guideline for CKD

Kidney Disease: Improving Global Outcomes has launched two implementation tools based on a 2020 clinical practice guideline for the management of diabetes in chronic kidney disease, according to a press release from the foundation.

News
September 20, 2021
2 min read
Save

Icosabutate rapidly reduces biomarkers of liver injury in NASH

Two doses of icosabutate were well tolerated and safe in patients with nonalcoholic steatohepatitis.